// App-Quantinova.ai

P1542 : COMORBIDITIES AND COMPLICATIONS ACROSS GENOTYPES IN ADULT PATIENTS WITH PYRUVATE KINASE DEFICIENCY: ANALYSIS FROM THE PEAK REGISTRY

Researchers

Presenter

  • Andreas Glenthj

Principal Investigators

  • Rachael F. Grace

  • Eduard J. van Beers

  • Joan-Lluis Vives Corrons

  • Bertil Glader

  • Kevin H. M. Kuo

  • Yan Yan

  • Paola Bianchi

Medical Centers

  • 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States

  • UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy

  • Metabolic Support UK,Wrexham,United Kingdom

  • Stanford University School of Medicine,Stanford, CA,Verenigde Staten

  • Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic

  • Stanford University School of Medicine,Stanford, CA,Verenigde Staten

  • AGIOS Pharmaceuticals Inc,Cambridge,United States

  • Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic

  • Division of Dermatology, University of Toronto, Toronto,Canada

  • Division of Dermatology, University of Toronto, Toronto,Canada

  • Metabolic Support UK,Wrexham,Vereinigtes Königreich

  • UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy

  • AGIOS Pharmaceuticals Inc,Cambridge,United States

  • Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne

  • Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos

  • Stanford University Medical Center, Stanford, California, United States

  • Department of Pediatrics,Palacky Unive

  • UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy

  • Stanford University School of Medicine,Stanford,Estados Unidos

  • Metabolic Support UK,Wrexham,Regno Unito

  • Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,Univers

  • Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne

  • Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas

  • Metabolic Support UK,Wrexham,Verenigd Koninkrijk

  • AGIOS Pharmaceuticals Inc,Cambridge,United States

  • Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas

  • UOC di Oncoematologia, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico di Milano, Milano, Italy

  • 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States

  • 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States

  • Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark

  • Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas

  • Division of Dermatology, University of Toronto, Toronto,Canada

  • Division of Hematology,University of Tor

  • Stanford University, CA

  • Metabolic Support UK,Wrexham,Соединённое Королевство

  • Metabolic Support UK,Wrexham,Royaume-uni

  • Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic

  • Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos

  • U.O. Oncoematologia,Fondazione IRCCS Ca' Granda Ospedale Mag

  • Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos

  • 4Dana-Farber/Boston Children's Cancer and Blood Disorders Center,Boston,United States

  • Dana-Farber/Boston Children's Cancer and Blood Disorder Center,B

  • Institute for Leukaemia Research Josep Carreras ENERCA Coordinator,University of Barcelona,Barcelona,Espagne

  • Department of Pediatrics, Palacky University and University Hospital, Olomouc, Czech Republic

  • Metabolic Support UK,Wrexham,Regno Unito

  • Van Creveldkliniek Department of Internal Medicine,University Medical Center Utrecht,Utrecht,Pays-bas

  • Agios Pharmaceuticals Inc.,Cambridge,Estados Unidos

  • Metabolic Support UK,Wrexham,Storbrita

  • Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark

  • Department of Hematology,

  • Department of Hematology, University Hospital Rigshospitalet, Copenhagen, Denmark

Locations

  • Denmark

  • United States

  • Netherlands

  • Venezuela

  • Canada

  • United Kingdom

  • Czech Republic

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Endocrine/metabolic Diseases (ME)

Disease

  • Pyruvate kinase (PK) deficiency

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

Phase

  • N/A

Study Id's

  • NCT03481738

Sponsors

  • N/A

Result

  • N/A